Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 2645-02-5 | MDL No. : | MFCD00558890 |
Formula : | C10H13NO4S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GYQBPYXMRNEAKZ-UHFFFAOYSA-N |
M.W : | 243.28 | Pubchem ID : | 562880 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.3 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 58.2 |
TPSA : | 80.85 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.95 cm/s |
Log Po/w (iLOGP) : | 2.01 |
Log Po/w (XLOGP3) : | 1.17 |
Log Po/w (WLOGP) : | 1.53 |
Log Po/w (MLOGP) : | 0.64 |
Log Po/w (SILICOS-IT) : | 0.64 |
Consensus Log Po/w : | 1.2 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.03 |
Solubility : | 2.26 mg/ml ; 0.00927 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.46 |
Solubility : | 0.837 mg/ml ; 0.00344 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.25 |
Solubility : | 0.137 mg/ml ; 0.000564 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.44 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With sodium carbonate In dichloromethane at 20℃; Cooling with ice | General procedure: Syntheses of G(2–4) and P(2–4): General experimental procedure is as follows: Glycine or L-phenyl alanine derivative (as HCl salt) (10 mmol) and Na2CO3 (2.1 g, 20 mmol) were dissolved in anhydrous dichloromethane (50 mL) and cooled in an ice bath before tosyl chloride (1.9 g, 10 mmol) was added. The resultant reaction mixture was stirred overnight at room temperature. After the reaction, more solvent was added and the residue was washed sequentially with 0.1 M HCl, saturated NaHCO3 and brine. Organic portion was dried with Na2SO4 and concentrated in vacuo to give crude product. The product was purified by column chromatography on silica with hexane and EtOAc (1:1). Compound G2: Yield 78percent as white solid. 1H NMR (400 MHz,CDCl3): δ 7.74 (d, J= 8.3 Hz, 2H, ArH), 7.31 (d, J= 8.3 Hz, 2H, ArH), 5.04 (t, J= 5.1 Hz, 1H, –NH–), 3.78 (d, J= 5.1 Hz, 2H, –CH2–), 3.64 (s, 3H, –OCH3), 2.42 (s, 3H, –CH3) ppm. 13C NMR (100 MHz, CDCl3): δ 169.4, 144.0, 136.3, 129.9, 127.4, 52.7, 44.2, 21.7 ppm. Anal.Calcd. [C10H13NO4S]: C, 49.37; H, 5.39; N, 5.76; S, 13.18. Found:C, 50.63; H, 5.09; N, 5.36; S, 12.87. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | at 20℃; for 3 h; | To a solution of (toluene-4-sulfonylamino)-acetic acid (2 g, 8.72 mmol) in methanol (60 mL), cone. H2SO4 (1.5 mL) was added. The mixture was stirred at room temperature for 3h then the solvent was removed under reduced pressure. The crude was dissolved in DCM (20 mL) and the organic phase was washed with H2O (1x20 mL), 5percent Na2CO3 (aq) (1x20 mL) and brine (1x20 mL). The organic layer was dried over Na2SO4 and the solvent was removed under reduced pressure. The crude (toluene-4-sulfonylamino)-acetic acid methyl ester was used in the next step without further purification. Yield: 98percent; LCMS (RT): 3.47 min (Method A); MS (ES+) gave m/z: 244.03 (MH+). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | With N-ethyl-N,N-diisopropylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 2 h; | General procedure: In an oven dried 25 mL R.B. flask equipped with magnetic stir bar, was loaded with TsOBt (289 mg, 1 mmol) in DCM (1 mL) followed by DIPEA (1 equiv.) was added. Then amine (1 equiv.) was added followed by 1 mL of DCM for amines and 1.5 mL of 1:3 DMF: DCM mixture for amino acid esters. The progress of the reaction was checked by TLC. After completion of the reaction, the reaction mixture was diluted with 10 mL of DCM and organic layer was washed with 5percent HCl (3.x.10 mL), 5percent NaHCO3 (3.x.10 mL), and saturated NaCl solution (2.x.10 mL) and dried over anhydrous CaCl2. Then it is dried in vaccuo and purified by column chromatography. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72.5% | Stage #1: With sodium methylate; potassium carbonate; potassium iodide In N,N-dimethyl-formamide at 50℃; for 1 h; Inert atmosphere Stage #2: With sodium methylate In methanol; N,N-dimethyl-formamide at 20℃; for 0.5 h; |
Methyl 2-(chloromethyl)-4-phenoxybenzoate (0.68 g, 2.46 mmol),N-p-toluenesulfonylglycine methyl ester (0.7 g, 2.88 mmol), potassium carbonate (0.68 g, 4.923 mmol), potassium iodide (0.16 g, 0.96 mmol), DMF was added to the reaction flask, replaced with nitrogen, and heated to 50 ° C. After reacting for 1 hour, 2 mL of methanolic sodium methoxide solution was added to room temperature and stirred for 30 min. After the reaction was completed by thin layer chromatography, 40 mL of purified water was added to the reaction mixture, and glacial acetic acid was added dropwise with stirring to adjust pH=7, suction filtration, and the filter cake was added with acetone. 4 mL was stirred for 2 hours, and suction filtered to give the title compound 2d (525 mg, 72.5percent). |
[ 21957-58-4 ]
(S)-2-(4-Methylphenylsulfonamido)propanoic acid
Similarity: 0.88
[ 86117-53-5 ]
(R)-2-(4-Methylphenylsulfonamido)-3-phenylpropanoic acid
Similarity: 0.78
[ 13505-32-3 ]
(S)-2-(4-Methylphenylsulfonamido)-3-phenylpropanoic acid
Similarity: 0.78